239 related articles for article (PubMed ID: 36502288)
1. The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review.
Llewellyn DC; Logan Ellis H; Aylwin SJB; Oštarijaš E; Green S; Sheridan W; Chew NWS; le Roux CW; Miras AD; Patel AG; Vincent RP; Dimitriadis GK
Obesity (Silver Spring); 2023 Jan; 31(1):20-30. PubMed ID: 36502288
[TBL] [Abstract][Full Text] [Related]
2. A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia.
Lobato CB; Pereira SS; Guimarães M; Hartmann B; Wewer Albrechtsen NJ; Hilsted L; Holst JJ; Nora M; Monteiro MP
Front Endocrinol (Lausanne); 2020; 11():608248. PubMed ID: 33424773
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Zhu Y; Xu J; Zhang D; Mu X; Shi Y; Chen S; Wu Z; Li S
Front Endocrinol (Lausanne); 2021; 12():769069. PubMed ID: 34956080
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis.
Pinelli NR; Hurren KM
Ann Pharmacother; 2011 Jul; 45(7-8):850-60. PubMed ID: 21730278
[TBL] [Abstract][Full Text] [Related]
5. Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery.
Malik S; Mitchell JE; Steffen K; Engel S; Wiisanen R; Garcia L; Malik SA
Obes Res Clin Pract; 2016; 10(1):1-14. PubMed ID: 26522879
[TBL] [Abstract][Full Text] [Related]
6. The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia.
Lu JM
Adv Ther; 2019 Apr; 36(4):798-805. PubMed ID: 30859500
[TBL] [Abstract][Full Text] [Related]
7. Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis.
Zaccardi F; Htike ZZ; Webb DR; Khunti K; Davies MJ
Ann Intern Med; 2016 Jan; 164(2):102-13. PubMed ID: 26642233
[TBL] [Abstract][Full Text] [Related]
8. Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists.
Ji Q
Clin Ther; 2017 Jun; 39(6):1244-1264. PubMed ID: 28526416
[TBL] [Abstract][Full Text] [Related]
9. An Imbalance of Pathophysiologic Factors in Late Postprandial Hypoglycemia Post Bariatric Surgery: A Narrative Review.
Alsayed Hasan M; Schwartz S; McKenna V; Ing R
Obes Surg; 2023 Sep; 33(9):2927-2937. PubMed ID: 37530920
[TBL] [Abstract][Full Text] [Related]
10. The incidence and risk factors associated with developing symptoms of hypoglycemia after bariatric surgery.
Lee CJ; Brown TT; Schweitzer M; Magnuson T; Clark JM
Surg Obes Relat Dis; 2018 Jun; 14(6):797-802. PubMed ID: 29678347
[TBL] [Abstract][Full Text] [Related]
11. Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review.
Albèr A; Brønden A; Knop FK
Diabetes Obes Metab; 2017 Jul; 19(7):915-925. PubMed ID: 28211611
[TBL] [Abstract][Full Text] [Related]
12. Fasting levels of glicentin are higher in Roux-en-Y gastric bypass patients exhibiting postprandial hypoglycemia during a meal test.
Poitou C; Bouaziz-Amar E; Genser L; Oppert JM; Lacorte JM; Le Beyec J
Surg Obes Relat Dis; 2018 Jul; 14(7):929-935. PubMed ID: 29703503
[TBL] [Abstract][Full Text] [Related]
13. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
[TBL] [Abstract][Full Text] [Related]
14. Effect of Glucagon-like Peptide-1 Receptor Agonists on Prognosis of Heart Failure and Cardiac Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Huixing L; Di F; Daoquan P
Clin Ther; 2023 Jan; 45(1):17-30. PubMed ID: 36604209
[TBL] [Abstract][Full Text] [Related]
15. A Pilot Study Examining the Effects of GLP-1 Receptor Blockade Using Exendin-(9,39) on Gastric Emptying and Caloric Intake in Subjects With and Without Bariatric Surgery.
Kittah E; Camilleri M; Jensen MD; Vella A
Metab Syndr Relat Disord; 2020 Nov; 18(9):406-412. PubMed ID: 32833560
[No Abstract] [Full Text] [Related]
16. GLP-1 Receptor Agonists: Practical Considerations for Clinical Practice.
Triplitt C; Solis-Herrera C
Diabetes Educ; 2015 Dec; 41(1 Suppl):32S-46S. PubMed ID: 26450217
[TBL] [Abstract][Full Text] [Related]
17. The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies.
Hindsø M; Svane MS; Hedbäck N; Holst JJ; Madsbad S; Bojsen-Møller KN
Surg Obes Relat Dis; 2021 Jul; 17(7):1383-1391. PubMed ID: 33771461
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints.
Patoulias D; Katsimardou A; Kalogirou MS; Zografou I; Toumpourleka M; Imprialos K; Stavropoulos K; Stergiou I; Papadopoulos C; Doumas M
Diabetes Metab; 2020 Sep; 46(4):272-279. PubMed ID: 32437914
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis.
Htike ZZ; Zaccardi F; Papamargaritis D; Webb DR; Khunti K; Davies MJ
Diabetes Obes Metab; 2017 Apr; 19(4):524-536. PubMed ID: 27981757
[TBL] [Abstract][Full Text] [Related]
20. Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.
Sloan LA
J Diabetes; 2019 Dec; 11(12):938-948. PubMed ID: 31318152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]